MBX (MBX Biosciences) Institutional Ownership: 115.24% (As of Jul. 06, 2026)


MBX MBX Biosciences Inc MBX
12 GF Score
Price $57.80
! 2 Warning Signs
View Full Analysis

What is MBX Biosciences Institutional Ownership?

MBX Biosciences MBX +3.42% 12 Institutional Ownership is 115.24% as of Jul. 06, 2026. GuruFocus rates MBX with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, MBX Biosciences's institutional ownership is 115.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, MBX Biosciences's Insider Ownership is 1.88%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, MBX Biosciences's Float Percentage Of Total Shares Outstanding is 71.26%.

MBX Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for MBX Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MBX Biosciences Institutional Ownership Chart

MBX Biosciences Historical Data

The historical data trend for MBX Biosciences can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 22.01 20.95 20.20 22.67 24.00 32.32 33.67 33.24 33.88 34.58
MBX
12GF Score
MBX Biosciences Inc MBX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MBX Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 115.24% mean?
MBX Biosciences (MBX) has a Institutional Ownership of 115.24% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on MBX Biosciences and its competitors.
Is MBX Biosciences' Institutional Ownership too high?
MBX Biosciences' current Institutional Ownership is 115.24%. Overall, MBX Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MBX Biosciences' Institutional Ownership compare to SLS and TRVI?
MBX Biosciences' Institutional Ownership of 115.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on MBX Biosciences and its competitors. MBX Biosciences's current Institutional Ownership is 115.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MBX Biosciences stock overvalued right now?
MBX Biosciences (MBX) has a current Institutional Ownership of 115.24%. The current Institutional Ownership is 115.24%. MBX Biosciences' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For MBX Biosciences (MBX), the current Institutional Ownership is 115.24% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MBX Biosciences Business Description

Address 11711 N. Meridian Street, Suite 300, Carmel, IN, USA, 46032
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
12GF Score

Get the complete analysis for MBX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$57.80
Price